AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 14.60
-0.10 (-0.68%)
Jan 22, 2026, 1:30 PM CST
AmCad BioMed Market Cap
AmCad BioMed has a market cap or net worth of 924.66 million as of January 22, 2026. Its market cap has decreased by -34.82% in one year.
Market Cap
924.66M
Enterprise Value
632.46M
Revenue
43.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.60
Market Cap Chart
Since December 26, 2013, AmCad BioMed's market cap has increased from 905.63M to 924.66M, an increase of 2.10%. That is a compound annual growth rate of 0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 924.66M | -0.68% |
| Dec 31, 2025 | 930.99M | -34.23% |
| Dec 31, 2024 | 1.42B | -0.45% |
| Dec 29, 2023 | 1.42B | 67.51% |
| Dec 30, 2022 | 848.88M | -17.57% |
| Dec 30, 2021 | 1.03B | 0.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OK Biotech | 2.10B |
| Cowealth Medical Holding | 1.72B |
| Bioptik Technology Incorporation | 1.59B |
| AViTA | 1.28B |
| Rossmax International | 1.25B |
| Wiltrom | 1.10B |
| Radiant Innovation | 826.19M |
| PlexBio | 784.63M |